Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RCC1 domain-containing protein 1 (RCCD1) is a member of the RCC1 superfamily, which includes proteins characterized by the presence of one or more RCC1 (Regulator of Chromosome Condensation 1) domains. These domains are beta-propeller folds involved in mediating protein–protein interactions and have diverse roles in cellular processes, depending on the specific family member[4][5]. The canonical RCC1 protein is a known guanine nucleotide exchange factor for Ran GTPase, critical in nuclear transport and mitosis, but the precise, specific molecular function of RCCD1 itself in human biology remains largely undescribed in available expert sources[5]. There is no current evidence that RCCD1 serves as a direct therapeutic target (receptor, enzyme, transporter) in human disease. Rationale & Supporting Details - Canonical Naming: Based on gene/protein databases and structural biology conventions, "RCC1 domain-containing protein 1" is the full, standard name for RCCD1[4][5]. - Abbreviation: "RCCD1" is the accepted short form, with "MGC14386" (a legacy gene identifier) as an alias. - Is Target: No evidence indicates RCCD1 itself is a direct drug target (such as a receptor, enzyme, or transporter), nor is there database information suggesting it is a current focus in therapeutic modulation, unlike canonical RCC1[1][2]. - Aliases: All collected from gene/protein databases and the provided query. - Molecular Family: RCCD1 is part of the RCC1 superfamily and more broadly fits under "Other" as a classification, since it does not fall under the standard classes like enzyme, receptor, etc.[4][5]. - Biological Functions: Unlike canonical RCC1, which is well characterized, RCCD1-specific biological function in humans is not well documented in the literature and major databases. All descriptions point only to its domain structure and potential for diverse protein/protein interactions[5]. - Disease Roles, Drugs, Biomarkers, Safety, Mechanism: No evidence or mention is found in the literature or major gene/protein resources for RCCD1 as a disease-associated gene, drug target, or biomarker. No interacting drugs or safety concerns are documented. - Description: Provided based on domain family characteristics, emphasizing the lack of direct experimental or clinical role for RCCD1 in humans in current sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RCC1 domain-containing protein 1 (RCCD1).